Page 1519 - Small Animal Internal Medicine, 6th Edition
P. 1519

CHAPTER 96   Polysystemic Viral Diseases   1491


            uniformly successful antiviral treatment has been developed,   to FIPV develop the syndrome of FIP. However, some
            and the drugs typically have potentially serious adverse   research cats that survived FIPV infection on primary expo-
  VetBooks.ir  effects. Cyclosporine A inhibits replication of feline corona-  sure developed FIP on subsequent inoculation suggesting
                                                                 that immunity is not permanent (Addie et al., 2001; Peder-
            viruses in vitro, but it is currently unknown whether this
            drug can be used successfully as a treatment of FIP (Tanaka
                                                                 is complex, cats with progeny that died of FIP should be
            et al., 2012). Small interfering RNA (siRNA) can be synthe-  sen et al., 2014a). Although the genetics of FIPV resistance
            sized and target different regions of the coronavirus genome   avoided for use for breeding programs in pedigreed catteries
            to inhibit viral replication in vitro and is another potential   (Pedersen et al., 2014).
            future treatment modality (McDonagh et al., 2011).     An intranasally administered, mutant strain of coronavi-
              Because disease from FIP is secondary to immune-   rus that induces mucosal immune response but minimal
            mediated reactions against the virus, modulation of the   systemic  immune  response  is  available  in  some  countries
            inflammatory reaction is the principal form of palliative   (Primucell FIP, Zoetis Animal Health). This strain does not
            therapy. Low-dose prednisolone (1-2 mg/kg orally [PO]   induce FIP; the majority of cats with adverse effects have
            q24h) may lessen clinical manifestations of noneffusive FIP.   exhibited only mild signs associated with placement of liquid
            However, the use of immunosuppressive drugs is controver-  in the nares, and the vaccine does not appear to potentiate
            sial because cats with FIP have impaired immune responses.   antibody-dependent enhancement of virus infectivity when
            Prednisolone and feline recombinant interferon were used   administered to previously seropositive cats. The vaccine
            in combination for the treatment of both effusive and nonef-  appears to be effective in at least some cats, but whether it
            fusive FIP in small numbers of cats (Ishida et al., 2004). In   protects against all field strains, mutations, or recombinants
            that study, four cats with effusive disease believed to be from   is unknown, so it is considered as noncore by the American
            FIP virus had prolonged remission. It is impossible to deter-  Association of Feline Practitioners (see  Chapter 93). Zoo-
            mine whether the effect was from the prednisolone or inter-  notic transfer of FIP virus or FECV to human beings has not
            feron because both drugs were administered to all cats. In   been documented.
            another study, administration of interferon-ω was ineffective
            for the treatment of FIP (Ritz et al., 2007). In the future,
            veterinarians may be able lessen inflammation and disease   FELINE IMMUNODEFICIENCY VIRUS
            induced by FIP by administering anti-feline tumor necrosis
            factor  monoclonal  antibodies  (Doki  et al.,  2016).  Immune   Etiology and Epidemiology
            modulation with polyprenyl immunostimulant may induce   FIV is an exogenous, single-strand RNA virus in the family
            beneficial effects in some cats with noneffusive FIP (Legen-  Retroviridae, subfamily Lentivirinae. The virus is morpho-
            dre and Bartges, 2009; Legendre et al., 2017).       logically similar to the human immunodeficiency virus
              Antibiotics do not have primary antiviral effects but may   (HIV), but it is antigenically distinct. Like FeLV, FIV pro-
            be indicated for the treatment of secondary bacterial infec-  duces reverse transcriptase to catalyze the insertion of viral
            tion. Other supportive care treatments such as anabolic   RNA into the host genome. Multiple clades of the virus exist,
            steroids (stanozolol, 1 mg PO q12h), aspirin (10 mg/kg PO   and some isolates have differing biologic behavior. For
            q48-72h), and ascorbic acid (125 mg PO q12h) have also   example, immune deficiency is induced much more quickly
            been recommended for the treatment of FIP. Most cats with   by  some  isolates,  and  clinical  diseases  such  as  uveitis  are
            systemic clinical signs of FIP die or require euthanasia within   induced by some but not all isolates. The prevalence of FIV
            days to months of diagnosis. The effusive form of disease   antibodies in United States and Canada was 3.6% in a 2017
            carries a grave prognosis. The drug propentofylline, used to   study (Burling et al., 2017), which is higher than the 2.5% in
            treat vasculitis, was evaluated in a placebo-controlled study   a study reported in 2006 (Levy et al., 2006). Regional varia-
            of naturally infected cats with effusive disease. However,   tions in prevalence rates for both FIV and FeLV exist (Chhetri
            the propentofylline protocol assessed did not improve the   et al., 2013).
            quality of life or lessen the effusion (Fischer et al., 2011).   FIV replicates readily in the oral lymphoid tissues (Miller
            Depending on the organ system involved and the sever-  et al., 2017). Aggressive biting behavior is thought to be the
            ity of polysystemic clinical signs, cats with noneffusive FIP   primary route of transmission of FIV; older, male, outdoor
            have variable survival times. Cats with only ocular FIP may   cats with clinical signs of disease are most commonly
            respond to antiinflammatory treatment or enucleation of the   infected. Plasma viral loads increase as the FIV disease
            affected eye(s) and have  a better prognosis than cats  with   severity increases (Kann et al., 2014). Vertical transmission
            systemic FIP.                                        appears to be unlikely to occur based on a study of group
                                                                 housed  shelter  cats  (Litster  et al.,  2014).  FIV is  present in
            Prevention and Zoonotic Aspects                      semen and can be transmitted by artificial insemination.
            Prevention of coronavirus infections is best accomplished by   Transplacental and perinatal transmission occurs from
            avoiding exposure to the virus. Although viral particles coro-  infected queens to kittens. Arthropod transmission appears
            naviruses can survive in dried secretions for up to 7 weeks,   to be unlikely. Transmission by routes other than biting is
            routine disinfectants inactivate the viruses. Some cats elimi-  less common because high levels of viremia are of short
            nate FECA coronavirus infections, and not all cats exposed   duration. FIV infection of cats has worldwide distribution,
   1514   1515   1516   1517   1518   1519   1520   1521   1522   1523   1524